Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 11, 2015 - Issue 7
Submit an article Journal homepage
1,672
Views
24
CrossRef citations to date
0
Altmetric
Short Report

CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma

Sara YousefHematology and Hematologic Malignancies; University of Utah; Huntsman Cancer Institute; Salt Lake City, UT, USA;Stem Cell Transplantation; University Medical Center Hamburg-Eppendorf; Hamburg, Germany
,
Magdalena Kovacsovics-BankowskiHematology and Hematologic Malignancies; University of Utah; Huntsman Cancer Institute; Salt Lake City, UT, USA
,
Mohamed E SalamaARUP Laboratories, Hematopathology; University of Utah; Salt Lake City, UT, USA;Department of Pathology; University of Utah; Salt Lake City, UT, USA
,
Neelam BhardwajHematology and Hematologic Malignancies; University of Utah; Huntsman Cancer Institute; Salt Lake City, UT, USA
,
Mary SteinbachHematology and Hematologic Malignancies; University of Utah; Huntsman Cancer Institute; Salt Lake City, UT, USA
,
Amanda LangemoHematology and Hematologic Malignancies; University of Utah; Huntsman Cancer Institute; Salt Lake City, UT, USA
,
Tibor KovacsovicsHematology and Hematologic Malignancies; University of Utah; Huntsman Cancer Institute; Salt Lake City, UT, USA
,
James MarvinFlow Cytometry Core Facility; University of Utah Health Sciences Center; Salt Lake City, UT, USA
,
Mascha BinderOncology, Hematology, Bone Marrow Transplantation with the Section Pneumology; University Medical Center Hamburg-Eppendorf; Hamburg, Germany
,
Jens PanseDepartment of Medicine IV; University Hospital RWTH Aachen; Aachen, Germany
,
Nicolaus KrögerStem Cell Transplantation; University Medical Center Hamburg-Eppendorf; Hamburg, Germany
,
Tim LuetkensHematology and Hematologic Malignancies; University of Utah; Huntsman Cancer Institute; Salt Lake City, UT, USA;Oncology, Hematology, Bone Marrow Transplantation with the Section Pneumology; University Medical Center Hamburg-Eppendorf; Hamburg, Germany
&
Djordje AtanackovicHematology and Hematologic Malignancies; University of Utah; Huntsman Cancer Institute; Salt Lake City, UT, USA;Oncology, Hematology, Bone Marrow Transplantation with the Section Pneumology; University Medical Center Hamburg-Eppendorf; Hamburg, GermanyCorrespondence[email protected]
 show all
Pages 1606-1611 | Received 05 Jan 2015, Accepted 26 Apr 2015, Published online: 06 Jul 2015

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Shebli Atrash & Tamara K Moyo. (2021) A Review of Chimeric Antigen Receptor T-Cell Therapy for Myeloma and Lymphoma. OncoTargets and Therapy 14, pages 2185-2201.
Read now
Sabarinath Venniyil Radhakrishnan, Neelam Bhardwaj, Tim Luetkens & Djordje Atanackovic. (2017) Novel anti-myeloma immunotherapies targeting the SLAM family of receptors. OncoImmunology 6:5.
Read now

Articles from other publishers (22)

Erica R. Vander Mause, Jillian M. Baker, Kenneth A. Dietze, Sabarinath V. Radhakrishnan, Thierry IraguhaDestiny Omili, Patricia DavisSadie L. ChidesterKatarzyna ModzelewskaJens Panse, James E. MarvinMichael L. OlsonMary Steinbach, David P. Ng, Carol S. Lim, Djordje Atanackovic & Tim Luetkens. (2023) Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity. Science Translational Medicine 15:705.
Crossref
Pooya Farhangnia, Shamim Mollazadeh Ghomi, Shabnam Mollazadehghomi, Hamid Nickho, Mahzad Akbarpour & Ali-Akbar Delbandi. (2023) SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy. Frontiers in Immunology 14.
Crossref
Qi Gao, Xueyan Chen, Sindhu Cherian & Mikhail Roshal. (2022) Mature B‐ and plasma‐cell flow cytometric analysis: A review of the impact of targeted therapy. Cytometry Part B: Clinical Cytometry 104:3, pages 224-242.
Crossref
Sandeep Rai, Nupur Das, Ritu Gupta, Lalit Kumar, Atul Sharma, Saroj Singh & Vijay K. Prajapati. (2022) Utility of CD229 as novel marker in measurable residual disease assessment in multiple myeloma —An evidence‐based approach . International Journal of Laboratory Hematology 45:2, pages 179-186.
Crossref
Zigen Lin, Xiaozhu Tang, Yuhao Cao, Lijin Yang, Mingmei Jiang, Xinying Li, Jie Min, Bing Chen, Ye Yang & Chunyan Gu. (2022) CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation. Aging 14:22, pages 9264-9279.
Crossref
R. Gupta, P. Gupta, K. Rahman, S. Biswas, D. Chandra, M. K. Singh, M. K. Sarkar, A. Gupta & S. Nityanand. (2021) Immunophenotypic Characterization and Ploidy Analysis of Neoplastic Plasma Cells by Multiparametric Flow Cytometry. Indian Journal of Hematology and Blood Transfusion 38:3, pages 473-480.
Crossref
Giovanna Roncador, Joan Puñet-Ortiz, Lorena Maestre, Luis Gerardo Rodríguez-Lobato, Scherezade Jiménez, Ana Isabel Reyes-García, Álvaro García-González, Juan F. García, Miguel Ángel Piris, Santiago Montes-Moreno, Manuel Rodríguez-Justo, Mari-Pau Mena, Carlos Fernández de Larrea & Pablo Engel. (2022) CD229 (Ly9) a Novel Biomarker for B-Cell Malignancies and Multiple Myeloma. Cancers 14:9, pages 2154.
Crossref
Xiangmin Wang, Bin Pan, He Huang & Kailin Xu. (2021) Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma. ImmunoMedicine 1:2.
Crossref
Kah Teong Soh, Joseph D. TarioJrJr, Theresa Hahn, Jens Hillengass, Philip L. McCarthy & Paul K. Wallace. (2020) CD319 (SLAMF7) an alternative marker for detecting plasma cells in the presence of daratumumab or elotuzumab. Cytometry Part B: Clinical Cytometry 100:4, pages 497-508.
Crossref
Faroogh Marofi, Safa Tahmasebi, Heshu Sulaiman Rahman, Denis Kaigorodov, Alexander Markov, Alexei Valerievich Yumashev, Navid Shomali, Max Stanley Chartrand, Yashwant Pathak, Rebar N. Mohammed, Mostafa Jarahian, Roza Motavalli & Farhad Motavalli Khiavi. (2021) Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism. Stem Cell Research & Therapy 12:1.
Crossref
Fabio NICOLINI, Sara BRAVACCINI, Massimiliano MAZZA, Alicja M. GRUSZKA, Marcella TAZZARI, Beatriz MARTÍN-ANTONIO, Manel JUAN, Toni IBRAHIM, Roberta MALTONI, Giovanni MARTINELLI & Claudio CERCHIONE. (2021) CAR T cells targeting options in the fight against multiple myeloma. Panminerva Medica 63:1.
Crossref
Mariko Ishibashi, Rimpei Morita & Hideto Tamura. (2021) Immune Functions of Signaling Lymphocytic Activation Molecule Family Molecules in Multiple Myeloma. Cancers 13:2, pages 279.
Crossref
Shebli Atrash, Syed Abbas Ali & Saad Z. Usmani. (2021) Chimeric Antigen Receptor T-cell Therapy for Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia 21:1, pages 21-34.
Crossref
Patrizia Leone, Antonio Giovanni Solimando, Eleonora Malerba, Rossella Fasano, Alessio Buonavoglia, Fabrizio Pappagallo, Valli De Re, Antonella Argentiero, Nicola Silvestris, Angelo Vacca & Vito Racanelli. (2020) Actors on the Scene: Immune Cells in the Myeloma Niche. Frontiers in Oncology 10.
Crossref
Luis Gerardo Rodríguez-Lobato, Maya Ganzetti, Carlos Fernández de Larrea, Michael Hudecek, Hermann Einsele & Sophia Danhof. (2020) CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions. Frontiers in Oncology 10.
Crossref
Mariko Ishibashi, Risa Takahashi, Asako Tsubota, Makoto Sasaki, Hiroshi Handa, Yoichi Imai, Norina Tanaka, Yutaka Tsukune, Sakae Tanosaki, Shigeki Ito, Toshio Asayama, Mika Sunakawa, Yuta Kaito, Yasuko Kuribayashi-Hamada, Asaka Onodera, Keiichi Moriya, Norio Komatsu, Junji Tanaka, Takeshi Odajima, Hiroki Sugimori, Koiti Inokuchi & Hideto Tamura. (2020) SLAMF3-Mediated Signaling via ERK Pathway Activation Promotes Aggressive Phenotypic Behaviors in Multiple Myeloma. Molecular Cancer Research 18:4, pages 632-643.
Crossref
Sabarinath V. Radhakrishnan, Tim Luetkens, Sandra D. Scherer, Patricia Davis, Erica R. Vander Mause, Michael L. Olson, Sara Yousef, Jens Panse, Yasmina Abdiche, K. David Li, Rodney R. Miles, William Matsui, Alana L. Welm & Djordje Atanackovic. (2020) CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide. Nature Communications 11:1.
Crossref
Marijke Timmers, Gils Roex, Yuedi Wang, Diana Campillo-Davo, Viggo F. I. Van Tendeloo, Yiwei Chu, Zwi N. Berneman, Feifei Luo, Heleen H. Van Acker & Sébastien Anguille. (2019) Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen. Frontiers in Immunology 10.
Crossref
Michael Olson, Sabarinath Venniyil Radhakrishnan, Tim Luetkens & Djordje Atanackovic. (2019) The role of surface molecule CD229 in Multiple Myeloma. Clinical Immunology 204, pages 69-73.
Crossref
Katharina Kriegsmann, Mark Kriegsmann, Martin Cremer, Michael Schmitt, Peter Dreger, Hartmut Goldschmidt, Carsten Müller-Tidow & Michael Hundemer. (2018) Cell-based immunotherapy approaches for multiple myeloma. British Journal of Cancer 120:1, pages 38-44.
Crossref
V. Innao, A. Allegra, S. Russo, D. Gerace, D. Vaddinelli, A. Alonci, A.G. Allegra & C. Musolino. (2017) Standardisation of minimal residual disease in multiple myeloma. European Journal of Cancer Care 26:6, pages e12732.
Crossref
Antonia Rotolo, Valentina Caputo & Anastasios Karadimitris. (2016) The prospects and promise of chimeric antigen receptor immunotherapy in multiple myeloma. British Journal of Haematology 173:3, pages 350-364.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.